LabGenius Announces Research Collaboration With Ablynx, a Sanofi Company
LabGenius, a pioneer in the use of machine learning (ML) for protein engineering, today announced the signing of a multi-year research collaboration with Ablynx, a Sanofi company.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005392/en/
LabGenius Announces Research Collaboration With Ablynx, a Sanofi Company (Photo: Business Wire)
Under the terms of the agreement, the companies will undertake a project, in the area of inflammation, that combines LabGenius’ capabilities in ML, robotic automation and synthetic biology with Ablynx’s expertise in NANOBODY® heavy chain variable domains. Over the course of the collaboration, LabGenius will use its EVATM platform to deliver optimized NANOBODY ® candidates. These molecules will then be progressed by Ablynx into further validation studies.
Dr James Field, CEO of LabGenius commented:
“We’re excited to be applying our ML-driven technology platform to support Ablynx in the optimization of novel NANOBODY® constructs. We’re hopeful that the fruits of this collaboration will ultimately have a positive impact on patients.”
Dr Edwin Moses, Chairman of LabGenius’ board and former CEO of Ablynx commented:
“Having had the pleasure of working with the Ablynx team in the past over many years, I am looking forward to this new collaboration that combines their world-leading expertise in NANOBODY® technology with LabGenius’ cutting-edge ML technology.”
Financial terms of the deal were not disclosed.
NANOBODY is a registered trademark of Ablynx N.V.
– end –
About LabGenius
LabGenius is a leading ML-driven protein engineering company. The company’s discovery platform, EVATM , integrates several cutting-edge technologies drawn from the fields of computer science, robotic automation and synthetic biology. Headquartered in London, UK, the LabGenius team includes experts in protein engineering, synthetic biology, software engineering, data science and robotic automation.
For more information, please visit www.labgeni.us, or connect on Twitter, Facebook, and LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210715005392/en/
Contact information
LabGenius
Lucy Shaw
Communications Lead
press@labgeni.us
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical to Announce Q3 2025 Financial Results on November 14 and Hold Earnings Call on November 1731.10.2025 14:00:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it will release its Q3 2025 financial results on Friday, November 14, 2025, before the U.S. market opens. The Company will hold a Earnings Call on Monday, November 17, 2025 at 5:00 p.m. Eastern Time to discuss the financial results and take questions live. Please register in advance for the conference using the link provided below. https://edge.media-server.com/mmc/p/e2znwqtx It will automatically direct you to the registration page for “SBC Q3 2025 Financial Results Presentation.” Please follow the steps to enter your registration details and click “Submit.” Upon registration, you will be able to access the dedicated conference call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well as pas
Motive Brings Seamless eSIM Activation to Luxury European Automotive Brand in Latin America31.10.2025 12:00:00 EET | Press release
Motive, a global leader in connected device lifecycle management and automation, has announced a landmark partnership with a leading operator in Central and South America, bringing seamless and secure mobile connectivity to a luxury European automotive brand’s vehicles in Mexico. The solution—powered by Motive's Entitlement Server—enables the carrier’s subscribers to link their mobile identities directly to their vehicles using embedded SIM (eSIM) technology leveraging GSMA’s mobile connectivity standards. This automotive-first for the Latin America region allows drivers to activate their mobile subscription upon entering a vehicle, delivering a personalized, connected experience on par with their smartphones. Whether for entertainment, navigation, or communication services, users benefit from uninterrupted access to their mobile services with enhanced security and privacy. "This deployment showcases the power of intelligent entitlement and provisioning," said Francisco Viana, VP Sales
Hanshow and Unide Partner to Advance Store Modernization under the “Plan Unide 2.0” Strategy31.10.2025 03:45:00 EET | Press release
Hanshow, a global leader in digital retail solutions, has announced a strategic collaboration with Unide Corporativa, one of Spain’s most established food retail cooperatives, to advance store digitalization and operational efficiency under its new strategic roadmap “Plan Unide 2.0” (2025–2028). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030921658/en/ Founded over 90 years ago, Unide unites hundreds of independent grocery retailers across Spain under a cooperative model built on proximity, freshness, and community service. With Plan Unide 2.0, the cooperative aims to strengthen competitiveness through member business development, store modernization, and new store openings—a roadmap to ensure sustainable growth in an evolving retail landscape. Unide faces operational challenges common to cooperative retail: manual paper label updates, inconsistent pricing, and limited promotional agility across its network. Meanwhile,
IFF Declares Dividend for Fourth Quarter 202530.10.2025 22:15:00 EET | Press release
IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 9, 2026 to shareholders of record as of December 19, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook. © 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved. View source version on businesswire.com: https://www.businesswire.com/news/home/20251030551985/en/
Rimini Street Announces Fiscal Third Quarter 2025 Financial and Operating Results30.10.2025 22:01:00 EET | Press release
Rimini Street, Inc. (the “Company”) (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, managed services and Agentic AI ERP innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced results for the fiscal third quarter ended September 30, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030625900/en/ Rimini Street Announces Fiscal Third Quarter 2025 Financial and Operating Results Select Third Quarter 2025 Financial Results Revenue was $103.4 million for the third quarter of 2025, a decrease of 1.2% compared to $104.7 million for the same period last year; excluding the wind down of support services for Oracle’s PeopleSoft software products, the revenue increased by 2.5%. U.S. revenue was $46.3 million for the third quarter of 2025, a decrease of 10.3% compared to $51.6 million for the same period last year; excluding the wind down
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom